The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold: A Multi-Imaging Modality Study
Open accessAbstract
Background—: Nonserial observations have shown this bioresorbable scaffold to have no signs of area reduction at 6 months and recovery of vasomotion at 1 year. Serial observations at 6 months and 2 years have to confirm the absence of late restenosis or unfavorable imaging outcomes. Methods and Results—: The ABSORB trial is a multicenter single-arm trial assessing the safety and performance of an everolimus-eluting bioresorbable vascular scaffold. Forty-five patients underwent serial invasive imaging, such as quantitative coronary angiography, intravascular ultrasound, and optical coherence tomography at 6 and 24 months of follow-up. From 6 to 24 months, late luminal loss increased from 0.16±0.18 to 0.27±0.20 mm on quantitative coronary angiography, with an increase in neointima of 0.68±0.43 mm 2 on optical coherence tomography and 0.17±0.26 mm 2 on intravascular ultrasound. Struts still recognizable on optical coherence tomography at 2 years showed 99% of neointimal coverage with optical and ultrasonic signs of bioresorption accompanied by increase in mean scaffold area compared with baseline (0.54±1.09 mm 2 on intravascular ultrasound, P =0.003 and 0.77±1.33 m 2 on optical coherence tomography, P =0.016). Two-year major adverse cardiac event rate was 6.8% without any scaffold thrombosis. Conclusions—: This serial analysis of the second generation of the everolimus-eluting bioresorbable vascular scaffold confirmed, at medium term, the safety and efficacy of the new device. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00856856.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serruys, P. W., Luijten, H. E., Beatt, K. J., Geuskens, R., de Feyter, P. J., van den Brand, M., Reiber, J. H., ten Katen, H. J., van Es, G. A., & Hugenholtz, P. G. (1988) · Circulation · doi:10.1161/01.cir.77.2.361 · Cited by 931
Self-citation
Cited by
Serruys, P. W., Chevalier, B., Dudek, D., Cequier, A., Carrié, D., Iniguez, A., Dominici, M., van der Schaaf, R. J., Haude, M., Wasungu, L., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61455-0 · Cited by 564
Self-citationBioresorbable scaffolds: rationale, current status, challenges, and future
Iqbal, J., Onuma, Y., Ormiston, J., Abizaid, A., Waksman, R., & Serruys, P. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht542 · Cited by 269
Self-citationA review on the thermomechanical properties and biodegradation behaviour of polyesters
Larrañaga, A., & Lizundia, E. (2019) · European Polymer Journal · doi:10.1016/j.eurpolymj.2019.109296 · Cited by 257
Current Status of Bioresorbable Scaffolds in the Treatment of Coronary Artery Disease
Wiebe, J., Nef, H. M., & Hamm, C. W. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.041 · Cited by 255
New concepts in the design of drug-eluting coronary stents
Garg, S., Bourantas, C., & Serruys, P. W. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.13 · Cited by 125
Self-citation
Metadata
- Authors
- Ormiston, J. A., Serruys, P. W., Onuma, Y., van Geuns, R.-J., de Bruyne, B., Dudek, D., Thuesen, L., Smits, P. C., Chevalier, B., McClean, D., Koolen, J., Windecker, S., Whitbourn, R., Meredith, I., Dorange, C., Veldhof, S., Hebert, K. M., Rapoza, R., & Garcia-Garcia, H. M.
- Venue
- Circulation: Cardiovascular Interventions
- Published
- 2012-10
- Volume
- 5
- Issue
- 5
- Pages
- 620-632
- ISSN
- 1941-7632 (ISSN-L)
- 1941-7640
- OpenAlex
- W2548646455
- Cited by
- 201
- References
- 1
- FWCI
- 30.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold: A Multi-Imaging Modality Study. https://app.cochat.ai/papers/10.1161/circinterventions.112.971549
- The paper
- Ormiston, J. A., Serruys, P. W., Onuma, Y., van Geuns, R.-J., de Bruyne, B., Dudek, D., Thuesen, L., Smits, P. C., Chevalier, B., McClean, D., Koolen, J., Windecker, S., Whitbourn, R., Meredith, I., Dorange, C., Veldhof, S., Hebert, K. M., Rapoza, R., & Garcia-Garcia, H. M. (2012). First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold: A Multi-Imaging Modality Study. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.112.971549
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.